IP Library Assignment 062042/0313
Patent Assignment
Reel/Frame 062042/0313

Assignment of Assignor's Interest

Recorded: 2022-12-09 Pages: 9
Assignors
TICAU, SIMINA
Executed: 2022-11-29
SRIDHARAN, GAUTHAM VIVEK
Executed: 2022-12-02
NIOI, PAUL
Executed: 2022-12-06
TSOUR, SHIRA
Executed: 2022-11-29
Assignee
ALNYLAM PHARMACEUTICALS, INC.
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MASSACHUSETTS, 02142-1110
Covered Properties (4)
Neurofilament Light Chain (Nfl) as a Biomarker for Transthyretin Amyloidosis Polyneuropathy
Application: 17/672,771 →
Publication: US 2023/0024849
Neurofilament Light Chain (Nfl) as a Biomarker for Transthyretin Amyloidosis Polyneuropathy
Application: 62/894,237 →
Neurofilament Light Chain (Nfl) as a Biomarker for Transthyretin Amyloidosis Polyneuropathy
Application: 62/925,623 →
Neurofilament Light Chain (Nfl) as a Biomarker for Transthyretin Amyloidosis Polyneuropathy
Application: 63/044,163 →
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →